A three-year study has found robust evidence that one particular vaccine for respiratory syncytial virus (RSV) offers older ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

The reported high prevalence amongst children also reflects what we know about this virus: it is a common cause of childhood respiratory ... This means that mutations are less frequent, with ...

In rare cases, researchers believe that lung cancer could be tied to inherited genetic mutations ... by a virus, is the result of the common influenza virus in adults. In children, the virus that ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting ...

GSK claims that Pfizer’s FDA-approved vaccine for respiratory syncytial virus infringes on four patents protecting its own approved vaccine, Arexvy. The patent suit comes with the RSV season ...